Therapeutics Related News

Cellectis Granted Patent for CRISPR Use in T-Cells

July 24, 2017 – New York (N.Y.) – Cellectis (Alternext: ALCLS; Nasdaq: CLLS), a clinical-stage biopharmaceutical company focused on developing immunotherapies based on gene-edited CAR T-cells (UCART), today announced the grant by the European Patent Office of patent No. EP3004337 for the invention [...]

By | July 25th, 2017|BioPharma & Healthcare, News, Press Releases, Therapeutics|

CRISPR Therapeutics and Neon Therapeutics Enter Research Collaboration

CAMBRIDGE, Mass. and BASEL, Switzerland, July 10, 2017 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (NASDAQ:CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for serious diseases, and Neon Therapeutics, an immuno-oncology company developing neoantigen-based therapeutic vaccines and T cell therapies to treat [...]

By | July 17th, 2017|BioPharma & Healthcare, News, Press Releases, Therapeutics|

US Patent Granted to AzarGen Biotechnologies for Synthetic Promoter Technology

STELLENBOSCH, South Africa, July 12, 2017 /PRNewswire/ -- AzarGen Biotechnologies (Pty) Ltd (Stellenbosch, South Africa) announced that it has received grant status for the patent application: SYNTHETIC PROMOTER CONSTRUCT FOR TRANSGENE EXPRESSION (US9670497) from the US Patent office. With special emphasis on the genetic [...]

By | July 17th, 2017|BioPharma & Healthcare, News, Press Releases, Therapeutics|

Horizon Discovery Takes Exclusive License for Novel Transposon-Based Gene Editing Technology Platform

Cambridge, UK, 05 July 2017: Horizon Discovery Group plc (LSE: HZD) ("Horizon" or “the Company”), the world leader in the application of gene editing technologies, today announces the completion of licensing agreements with all joint patent holders to provide exclusive [...]

By | July 10th, 2017|BioPharma & Healthcare, News, Press Releases, Therapeutics|

CRISPR: A Present-Day Guide to the current CRISPR Innovation Landscape

It has been over a year since Broad Institute scientist, David MacArthur started the epic #crisprfacts Twitterstorm which started as a sarcastic rebuttal to claims that Wired’s August 2016 cover story made about CRISPR. The article’s claims when taken in [...]

By | July 7th, 2017|Agriculture, BioPharma & Healthcare, News, Therapeutics|

Flagship Pioneering Announces Launch of Sigilon Therapeutics to Harness the Full Power of Cell Therapeutics

Flagship Pioneering announced the launch of its newest biotech firm, Sigilon Therapeutics on Wednesday, June 21st, with  a $23.5 million round of financing and is the latest company in a line of Cambridge/Boston biotechs to come out of VentureLabs, Flagship’s in-house [...]

By | July 5th, 2017|BioPharma & Healthcare, News, Press Releases, Therapeutics|